ADVERTISEMENT
Aurora Cannabis Inc. is urging its shareholders to reject a hostile takeover bid by Curaleaf Holdings, Inc., saying the unsolicited offer undervalues Aurora and is not in the best interests of shareholders.
Cannabis company Organigram Global Inc. says the acquisition of a European medical cannabis company has helped drive it to record quarterly revenues.
Curaleaf Holdings Inc. says it intends to launch a takeover bid for Edmonton-based cannabis company Aurora Cannabis Inc.
A national cannabis lobby group representing licensed producers and processors is suspending operations, citing challenges tied to the unregulated cannabis market.
While no one expects cannabis to overshadow the action on the field, many foresee at least a marginal lift in pot sales and dispensary foot traffic when Toronto and Vancouver play host for their combined 13 matches in June and July.
U.S. President Donald Trump’s decision to reclassify state-licensed medical marijuana as a less dangerous drug is a boon for the industry: It gives dispensaries a big tax break, eases some barriers to researching cannabis and could even allow the export of marijuana to other countries.
The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S. cannabis market, experts and industry executives said, as retailers adjust product offerings to suit changing consumer behaviour tied to the therapies.
U.S. President Donald Trump on Thursday signed an order recommending the loosening of federal regulations on marijuana, a move that could further reverse decades of tough-on-weed policy.
U.S. President Donald Trump is expected to sign an executive order on Thursday reclassifying marijuana to ease federal restrictions, according to CNN, which cited a source familiar with the planning and a senior White House official.
Luc Mongeau, CEO of Canopy Growth, joins BNN Bloomberg to discuss the company's arrangement agreement to acquire MTL Cannabis.
Canopy Growth Corp. has signed a deal to buy Quebec-based MTL Cannabis Corp. in a transaction valued at about $125 million
Dan Ahrens, managing director, chief operating officer, and portfolio manager at Advisor Shares, joins BNN Bloomberg to discuss the outlook on cannabis stocks.
Shares in Canada’s cannabis companies surged after reports U.S. President Donald Trump is planning to ease federal restrictions on the drug.
Vahan Ajamian, capital markets analyst at High Tide Inc., joins BNN Bloomberg to discuss cannabis stocks amid U.S. reclassification and what that could mean.
Raj Grover, Founder and Chief Executive Officer of High Tide, joins BNN Bloomberg to discuss the company's expansion into the German medical cannabis market.
Beena Goldenberg, CEO of Organigram Global, joins BNN Bloomberg to discuss the company's acquisition of Motif as their outlook for the future.
